Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00229450 · ClinicalTrials.gov registry record · Phase 4
Estrogen and Perimenopausal Depression
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT00229450 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 17 participants.
The verdict
NCT00229450, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
During perimenopause (the time just prior to menopause), women often notice many biological, psychological, and social changes. In particular, some women experience depressive symptoms during perimenopause that are severe enough to warrant antidepressant medication. Whether or not women with perimenopausal depression respond to antidepressant medication may depend on the level of estrogen in their blood. This study will investigate whether estrogen will help women who only partially respond to antidepressant medications, as well as examine how different doses of estrogen may affect individuals differently.
Interventions
- DRUG Estrogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2002-04 |
| Est. Completion | 2004-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00229450
The ClinicalTrials.gov registry entry for NCT00229450 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Estrogen is the first listed.
NCT00229450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00229450 about?
NCT00229450 is a clinical study titled "Estrogen and Perimenopausal Depression". During perimenopause (the time just prior to menopause), women often notice many biological, psychological, and social changes. In particular, some women experience depressive symptoms during perimenopause that are severe enough to warrant antidepressant medication. Whether or not women with perimen...
What is the current status of trial NCT00229450?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2002-04. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00229450?
The interventions under investigation include: Estrogen (DRUG).
Who is sponsoring clinical trial NCT00229450?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.